 |
|
Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children With Anthrax
JAMA. 2001;286:2663-2664.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2001;50:1014-16
Ciprofloxacin or doxycycline is recommended for antimicrobial prophylaxis and treatment of adults and children with Bacillus anthracis infection associated with the recent bioterrorist attacks in the United States. Amoxicillin is an option for antimicrobial prophylaxis for children and pregnant women and to complete treatment of cutaneous disease when B. anthracis is susceptible to penicillin, as is the case in the recent attacks.1-3 Use of ciprofloxacin or doxycycline might be associated with adverse effects in children,4,5 and liquid formulations of these drugs are not widely available. This notice provides further information about prophylaxis and treatment of children and breastfeeding mothers, including the use of amoxicillin.
Ciprofloxacin, doxycycline, and penicillin G procaine have been effective as antimicrobial prophylaxis for inhalational B. anthracis infection in nonhuman primates and are approved for this use in humans by the Food and Drug Administration (FDA).5,6 Amoxicillin has not been studied in animal models and . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Modeling the Logistics of Response to Anthrax Bioterrorism
Zaric et al.
Med Decis Making 2008;28:332-350.
ABSTRACT
|
